Tarsus Pharmaceuticals News and Activities

Presence

Tarsus Pharmaceuticals develops and sells prescription medicines for eye care and other specialty conditions. Its products and research programs serve ophthalmologists, eye care professionals, and patients in the United States.

Tarsus Pharmaceuticals products and services overview:

Eye care therapies
Prescription medicines
Ophthalmic treatments
Specialty pharmaceuticals
Clinical research

Revenue: ~$180 million

Employees: 300

Headquarters: Irvine, United States (USA)

Tarsus Pharmaceuticals is one of the...

Tarsus Pharmaceuticals is a company listed under the stock ticker TARS (US).

Executives

View the org chart displaying its 28 main executives

Most searched biographies at Tarsus Pharmaceuticals

Popular executive movements at Tarsus Pharmaceuticals

David Pyott has joined the company as Director (posted on February 19 2026).
Georgea Pasedis has joined the company as Vice President, Medical Affairs (posted on October 1 2025).

Create your alert
to follow the executive moves at Tarsus Pharmaceuticals.